Nebivolol and Endothelial Regulation of Fibrinolysis

Trial Profile

Nebivolol and Endothelial Regulation of Fibrinolysis

Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol
  • Indications Hypertension
  • Focus Biomarker; Pharmacodynamics
  • Acronyms NERF
  • Most Recent Events

    • 24 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 04 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top